ACET
Adicet Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.53
−0.88%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$1.99
- EPS estimate
- -$1.69
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.4%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $51
- PT range
- $28 – $90
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$1.69 | -$1.99 | Miss -17.75% | — |
| May 13, 2026 | -$2.93 | -$1.88 | Beat 35.84% | — |
| Mar 12, 2026 | -$2.91 | -$2.94 | Miss -1.03% | — |
| Nov 5, 2025 | -$4.16 | -$4.64 | Miss -11.54% | — |
| Aug 7, 2025 | -$5.12 | -$5.44 | Miss -6.25% | — |
| Mar 6, 2025 | -$5.92 | -$5.12 | Beat 13.51% | — |
| May 14, 2024 | -$5.60 | -$5.60 | In line | — |
| Mar 19, 2024 | -$12 | -$11 | Beat 4.17% | — |
| Mar 15, 2023 | -$8.96 | -$12 | Miss -28.57% | — |
| Aug 10, 2022 | -$7.20 | -$8.96 | Miss -24.44% | — |
| May 12, 2022 | -$1.12 | $1.60 | Beat 242.86% | $25.0M |
| Mar 15, 2022 | -$7.04 | -$7.52 | Miss -6.82% | $5.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026